PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism

. 2019 Apr ; 42 (4) : 419-426. [epub] 20180809

Jazyk angličtina Země Itálie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid30094743
Odkazy

PubMed 30094743
DOI 10.1007/s40618-018-0931-z
PII: 10.1007/s40618-018-0931-z
Knihovny.cz E-zdroje

PURPOSE: Identification of pathologic parathyroid glands in primary hyperparathyroidism, traditionally based on neck ultrasound (US) and/or 99mTc-Sestamibi scintigraphy, can be challenging. PET/CT with 18F-Fluorocholine (18F-FCH) might improve the detection of pathologic parathyroid glands. We aimed at comparing the diagnostic performance of 18F-FCH-PET/CT with that of dual-phase dual-isotope parathyroid scintigraphy and neck US. METHODS: Thirty-four consecutive patients with primary hyperparathyroidism were prospectively enrolled, 7 had normocalcemic hyperparathyroidism, and 27 had classic hypercalcemic hyperparathyroidism. All patients underwent high-resolution neck US, dual-phase dual-isotope 99mTc-Pertechnetate/99mTc-Sestamibi scintigraphy, and 18F-FCH-PET/CT. RESULTS: In the whole patients' group, the detection rates of the abnormal parathyroid gland were 68% for neck US, 71% for 18F-FCH-PET/CT, and only 15% for 99mTc-Sestamibi scintigraphy. The corresponding figures in normocalcemic and hypercalcemic hyperparathyroidism were 57 and 70% for neck US, 70 and 71% for 18F-FCH-PET/CT, and 0 and 18% for 99mTc-Sestamibi scintigraphy, respectively. In the 17 patients in whom the abnormal parathyroid gland was identified, either at surgery or at fine needle aspiration cytology/biochemistry, the correct detection rate was 82% for neck US, 89% for 18F-FCH-PET/CT, and only 17% for 99mTc-Sestamibi scintigraphy. CONCLUSIONS: 18F-FCH-PET/CT can be considered a first-line imaging technique for the identification of pathologic parathyroid glands in patients with normocalcemic and hypercalcemic hyperparathyroidism, even when the parathyroid volume is small.

Zobrazit více v PubMed

J Nucl Med. 2003 Sep;44(9):1443-58 PubMed

Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72 PubMed

Laryngoscope. 2006 Apr;116(4):580-5 PubMed

J Clin Endocrinol Metab. 2007 Aug;92(8):3001-5 PubMed

J Clin Endocrinol Metab. 2009 Feb;94(2):335-9 PubMed

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):106-9 PubMed

World J Surg. 2012 Apr;36(4):761-6 PubMed

J Clin Endocrinol Metab. 2013 Jul;98(7):2734-41 PubMed

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2083-9 PubMed

J Clin Endocrinol Metab. 2014 Dec;99(12):4531-6 PubMed

J Clin Endocrinol Metab. 2015 Jun;100(6):2420-4 PubMed

Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1941-2 PubMed

Endocr Pract. 2016 Mar;22(3):294-301 PubMed

Langenbecks Arch Surg. 2016 Nov;401(7):925-935 PubMed

Nucl Med Mol Imaging. 2016 Jun;50(2):180-2 PubMed

Can Assoc Radiol J. 2017 Feb;68(1):47-55 PubMed

Clin Nucl Med. 2017 Dec;42(12):e491-e497 PubMed

J Nucl Med. 1998 May;39(5):822-5 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...